Pluristem Therapeutics (PSTI) Stock Climbs on FDA News

By |December 31st, 2015|

Pluristem Therapeutics Inc. (NASDAQ: PSTI)

Pluristem is having an incredible day in the market today, defying the overall movement we’re seeing market wide. The gains we’re seeing today are for a very good reason. The company has received Orphan Drug Designation for a treatment in the pipeline. Today, we’ll talk about the Orphan Drug Designation, […]